Electroconvulsive therapy (ECT), also known as electroshock, is a well established, albeit controversial psychiatric treatment in which seizures are electrically induced in anesthetized patients for therapeutic effect. Today, ECT is most often used as a treatment for severe major depression which has not responded to other treatment, and is also used in the treatment of mania (often in bipolar disorder), catatonia, schizophrenia and other disorders. It was first introduced in the 1930s and gained widespread use as a form of treatment in the 1940s and 1950s; today, an estimated 1 million people worldwide receive ECT every year, usually in a course of 6-12 treatments administered 2 or 3 times a week. Electroconvulsive therapy can differ in its application in three ways; electrode placement, length of time that the stimulus is given, and the property of the stimulus. The variance of these three forms of application have significant differences in both adverse side effects and positive outcomes. In a study, ECT was shown clinically to be the most effective treatment for severe depression, and to result in improved quality of life in both short- and long-term. After treatment, drug therapy can be continued, and some patients receive continuation/maintenance ECT. The American Psychiatric Association and the British National Institute for Health and Clinical Excellence have concluded that the procedure does not cause brain damage in adults. Certain types of ECT have been shown to cause persistent memory loss, whereas confusion usually clears within hours of treatment. Informed consent is a standard of modern electroconvulsive therapy. Involuntary treatment is uncommon in countries that follow contemporary standards, but is becoming increasingly common in treatment of the elderly. Involuntary ECT is typically only used when the use of ECT is believed to be potentially life saving.
There is considerable variability among practitioners in the frequency with which ECT is used as first-line/primary treatment or is only considered for secondary use after patients have not responded to other interventions.
The APA 2001 guidelines give the primary indications for ECT among patients with depression as a lack of a response to, or intolerance of, antidepressant medications; a good response to previous ECT; and the need for a rapid and definitive response (e.g. because of psychosis or a risk of suicide). The decision to use ECT depends on several factors, including the severity and chronicity of the depression, the likelihood that alternative treatments would be effective, the patient's preference, and a weighing of the risks and benefits.
Some guidelines recommend that cognitive behavioral therapy or other psychotherapy should generally be tried before ECT is used. However, treatment resistance is widely defined as lack of therapeutic response to two antidepressants. The APA states that at times patients will prefer to receive ECT over alternative treatments, but commonly the opposite will be the case.
The APA ECT guidelines state that severe major depression with psychotic features, manic delirium, or catatonia are conditions for which there is a clear consensus favoring early reliance on ECT. The NICE guidelines recommend ECT for patients with severe depression, catatonia, or prolonged or severe mania.
The 2001 APA guidelines support the use of ECT for relapse prevention, but the 2003 NICE guidelines do not.
The 2001 APA ECT guidelines say that ECT is rarely used as a first-line treatment for schizophrenia but is considered after unsuccessful treatment with antipsychotic medication, and may also be considered in the treatment of patients with schizoaffective or schizophreniform disorder. The 2003 NICE ECT guidelines do not recommend ECT for Schizophrenia.
The NICE 2003 guidelines state that doctors should be particularly cautious when considering ECT treatment for women who are pregnant and for older or younger people, because they may be at higher risk of complications with ECT. The 2001 APA ECT guidelines say that ECT may be safer than alternative treatments in the infirm elderly and during pregnancy, and the 2000 APA depression guidelines stated that the literature supports the safety for mother and fetus, as well as the efficacy during pregnancy.
Non-clinical patient characteristicsEdit
About seventy percent of ECT patients are women.This is largely, but not entirely, due to the fact that women are more likely to receive treatment for depression. Older and more affluent patients are also more likely to receive ECT. The use of ECT treatment is "markedly reduced for ethnic minorities."
In the US the 1999 Surgeon General's report on mental health summarised psychiatric opinion at the time about the effectiveness of ECT. It stated that both clinical experience and controlled trials had determined ECT to be effective (with an average 60 to 70 percent remission rate) in the treatment of severe depression, some acute psychotic states, and mania. Its effectiveness had not been demonstrated in dysthymia, substance abuse, anxiety, or personality disorder. The report stated that ECT does not have a long-term protective effect against suicide and should be regarded as a short-term treatment for an acute episode of illness, to be followed by continuation therapy in the form of drug treatment or further ECT at weekly to monthly intervals. A 2004 large multicentre clinical follow-up study of ECT patients in New York - describing itself as the first systematic documentation of the effectiveness of ECT in community practice in the 65 years of its use - found remission rates of only 30-47 percent, with 64 percent of those relapsing within six months. A survey of New York psychiatrists found that they thought that 85 percent of their patients benefited from ECT.
In the UK in 2003 the UK ECT Review Group, led by Professor Geddes of Oxford University, reviewed the evidence and concluded that ECT had been shown to be an effective short-term treatment for depression (as measured by symptom rating scales) in physically healthy adults, and that it was probably more effective than drug treatment. Bilateral ECT was more effective than unilateral, and high-dose was more effective than low-dose. Their conclusions were qualified: most of the trials were old and conducted on small numbers of patients; some groups (for example, elderly people, women with postpartum depression and people with treatment-resistant depression) were under-represented in the trials even though ECT is believed to be especially effective for them.
ECT on its own does not usually have a sustained benefit - virtually all those who remit end up relapsing within 6 months following a course, even when given a placebo. The relapse rate in the first six months may be reduced by the use of psychatric medications or further ECT, but remains high.
Once the decision has been made for a patient to have ECT there is usually a pretreatment evaluation that determines what factors will allow for maximum benefits and minimize risk. Informed consent is also sought before treatment. Patients are informed about the risks and benefits of the procedure. Patients are also made aware of risks and benefits of other treatments and of not having the procedure done at all. Depending on the jurisdiction the need for further inputs from other medical professionals or legal professionals may be required. ECT is usually given on an in-patient basis, although it may also be given on an out-patient basis. Prior to treatment a patient is given a short-acting anesthetic such as methohexital, propofol, etomidate and thiopental, a muscle relaxant such as suxamethonium (succinylcholine), and occasionally atropine to inhibit salivation.
Electrodes are usually placed one on either side of the patient's head. This is known as bilateral ECT. Less frequently both electrodes are placed on one side of the head. This is known as unilateral ECT. In bifrontal ECT, an uncommon variation, the electrode position is somewhere between bilateral and unilateral. Unilateral is thought to cause fewer cognitive effects than bilateral but is considered less effective. In the USA most patients receive bilateral ECT. In the UK almost all patients receive bilateral ECT.
The electrodes deliver an electrical stimulus. The stimulus levels recommended for ECT are in excess of an individual's seizure threshold: about one and a half times seizure threshold for bilateral ECT and up to 12 times for unilateral ECT. Below these levels treatment may not be effective in spite of a seizure, while doses massively above threshold level, especially with bilateral ECT, expose patients to the risk of more severe cognitive impairment without additional therapeutic gains. Seizure threshold is determined by trial and error ("dose titration"). Some psychiatrists use dose titration, some still use "fixed dose" (that is, all patients are given the same dose) and others compromise by roughly estimating a patient's threshold according to age and sex. Older men tend to have higher thresholds than younger women, but it is not a hard and fast rule, and other factors, for example drugs, affect seizure threshold.
Most modern ECT machines deliver a brief-pulse current, which is thought to cause fewer cognitive effects than the sine-wave currents which were originally used in ECT. A small minority of psychiatrists in the USA still use sine-wave stimuli. Sine-wave is no longer used in the UK. Typically, the electrical stimulus used in ECT is about 800 milliamps, and the current flows for between one and 6 seconds. In the USA, ECT machines are manufactured by two companies, Somatics, which is owned by psychiatrists Richard Abrams and Conrad Swartz, and MECTA. The Food and Drug Administration has classified the devices used to administer ECT as Class III medical devices. Class III is the highest-risk class of medical devices. In the UK the market for ECT machines was long monopolised by Ectron Ltd, although in recent years some hospitals have started using American machines. Ectron Ltd was set up by psychiatrist Robert Russell, who together with a colleague from the Three Counties Asylum, Bedfordshire, invented the Page-Russell technique of intensive ECT.
Variations in international practiceEdit
There is wide variation in ECT use between different countries, different hospitals, and different psychiatrists. International practice varies considerably from widespread use of the therapy in many western countries to a small minority of countries that do not use ECT at all, such as Slovenia. Guidelines on the use of ECT are stringent in the USA and the UK. Modern standards are not always followed throughout the world and not all countries that use ECT have written technical standards. The use of both anesthesia and muscle relaxants is universally recommended in the administration of ECT. If anesthesia and muscle relaxants are not used the procedure is called unmodified ECT. In a minority of countries such as Japan, India, and Nigeria, ECT may be used without anesthesia. WHO has called for a world wide ban on unmodified ECT and the topic is currently being debated in countries like India. The practice has been recently abolished in Turkey's largest psychiatric hospital. A major difficulty for developing countries in eliminating unmodified ECT is a lack of trained anesthetists available to administer the procedure. A small minority of countries never seek consent before administering ECT. This significantly uneven application of ECT around the world continues to make ECT a controversial procedure.
In the USA, a survey of psychiatric practice in the late 1980s found that an estimated 100,000 people received ECT annually, with wide variation between metropolitan statistical areas. Accurate statistics about the frequency, context and circumstances of ECT in the United States are difficult to obtain because only a few states have reporting laws that require the treating facility to supply state authorities with this information. One state which does report such data is Texas, where in the mid-1990s ECT was used in about one third of psychiatric facilities and given to about 1,650 people annually. Usage of ECT has since declined slightly; in 2000-01 ECT was given to about 1,500 people aged from 16 to 97 (in Texas it is illegal to give ECT to anyone under sixteen). ECT is more commonly used in private psychiatric hospitals than in public hospitals and minority patients are underrepresented in the ECT statistics. In the United States ECT is usually given three times a week; in the UK it is usually given twice a week. Occasionally it is given on a daily basis. A course usually consists of 6-12 treatments, but may be more or fewer. Following a course of ECT some patients may be given continuation or maintenance ECT with further treatments at weekly, fortnightly or monthly intervals. A few psychiatrists in the USA use multiple-monitored ECT (MMECT) where patients receive more than one treatment per anesthetic. As of 2007, electroconvulsive therapy practice is not officially regulated in the USA, and the education of physicians in its prescription and administration has been described as poor. Electroconvulsive therapy is not a required subject in US medical schools and not a required skill in psychiatric residency training. Privileging for ECT practice at institutions is a local option, no national certification standards are established, and no ECT-specific continuing training experiences are required of ECT practitioners.
In the United Kingdom in 1980, an estimated 50,000 people received ECT annually, with use declining steadily since then to about 12,000 per annum. It is still used in nearly all psychiatric hospitals, with a survey of ECT use from 2002 finding that 71 percent of patients were women and 46 percent were over 65 years of age. Eighty-one percent had a diagnosis of mood disorder; schizophrenia was the next most common diagnosis. Sixteen percent were treated without their consent. In 2003 the National Institute for Clinical Excellence, a government body which was set up to standardize treatment throughout the National Health Service, issued guidance on the use of ECT. Its use was recommended "only to achieve rapid and short-term improvement of severe symptoms after an adequate trial of treatment options has proven ineffective and/or when the condition is considered to be potentially life-threatening in individuals with severe depressive illness, catatonia or a prolonged manic episode". The guidance got a mixed reception. It was welcomed by an editorial in the British Medical Journal but the Royal College of Psychiatrists launched an unsuccessful appeal. The NICE guidance, as the British Medical Journal editorial points out, is only a policy statement and psychiatrists may deviate from it if they see fit. Adherence to standards has not been universal in the past. A survey of ECT use in 1980 found that more than half of ECT clinics failed to meet minimum standards set by the Royal College of Psychiatrists, with a later survey in 1998 finding that minimum standards were largely adhered to, but that two-thirds of clinics still fell short of current guidelines, particularly in the training and supervision of junior doctors involved in the procedure. A voluntary accreditation scheme, ECTAS, was set up in 2004 by the Royal College, but as of 2006 only a minority of ECT clinics in England, Wales, Northern Ireland and the Republic of Ireland have signed up.
Sarah Hall reports, "ECT has been dogged by conflict between psychiatrists who swear by it, and some patients and families of patients who say that their lives have been ruined by it. It is controversial in some European countries such as Holland and Italy, where its use is severely restricted".
The physical risks of ECT are similar to those of brief general anesthesia; the United States' Surgeon General's report says that there are "no absolute health contraindications" to its use. Immediately following treatment the most common adverse effects are confusion and memory loss. The state of confusion usually disappears after an hour.
Effects on cognition and memoryEdit
It is the effects of ECT on long-term memory that give rise to much of the concern surrounding its use.The acute effects of ECT include amnesia, both retrograde (for events occurring before the treatment) and anterograde (for events occurring after the treatment). Memory loss and confusion are more pronounced with bilateral electrode placement rather than unilateral, and with sine-wave rather than brief-pulse currents. The vast majority of modern treatment uses brief pulse currents. Retrograde amnesia is most marked for events occurring in the weeks or months before treatment, with one study showing that although some people lose memories from years prior to treatment, recovery of such memories was "virtually complete" by seven months post-treatment, with the only enduring loss being of memories in the weeks prior to the treatment. Later research by the same author suggested memory of events in the months prior to treatment might be lost, as well as suggesting that self-report of memory loss was in fact a problem before treatment which patients associated with it. Further reviews have supported the idea that reports of memory loss are due to somatoform disorders and not to brain damage. Anterograde memory loss is usually limited to the time of treatment itself or shortly afterwards. In the weeks and months following ECT these memory problems gradually improve, but some people have persistent losses, especially with bilateral ECT. One review of patient self-reporting found that between 29 percent and 55 percent (depending on the study) of people who had undergone ECT reported persistent memory loss. In 2000 American psychiatrist Sarah Lisanby and colleagues found that bilateral ECT left patients with persistent impairment for memory of public events" as compared to RUL ECT. A large study (250 subjects), published January 2007 by Harold Sackeim and colleagues found that some forms (namely bilateral application and sine wave currents) of ECT "routine[ly]" causes "adverse cognitive effects," including cognitive dysfunction and memory loss, that can persist for an extended period. The same study determined that the cognitive deficits produced by ECT were more pronounced in women than in men. Formal neuropsychological testing has documented permanent neuropsychological deficits in patients who receive certain types of ECT treatment, A recent article by a neuropsychologist and a psychiatrist in Dublin suggests that ECT patients who experience cognitive problems following ECT should be offered some form of cognitive rehabilitation. The authors say that the failure to attempt to rehabilitate patients may be partly responsible for the negative public image of ECT.
A study published in 2004 in the "Journal of Mental Health" reported that 35 to 42% of patients said ECT resulted in loss of intelligence. The study also reported, "There is no overlap between clinical and consumer studies on the question of benefit."
Effects on brain structureEdit
A number of national mental health institutions have concluded that there is no evidence that ECT causes structural brain damage in adults. A 1999 report by the United States Surgeon General stated, "The fears that ECT causes gross structural brain pathology have not been supported by decades of methodologically sound research in both humans and animals". All of the recent scientific reviews on this topic which reviewed the body of ECT research using autopsies, brain imaging, and animal studies of electroconvulsive therapy, have also concluded that there is no evidence that ECT causes brain damage. Current research is examining the possibility that, "...rather than cause brain damage, there is evidence that ECT may reverse some of the damaging effects of serious psychiatric illness" However, as of 2003 there had been no studies on the impact of ECT on the developing brain.
Effects in pregnancyEdit
ECT is generally accepted to be relatively safe during all trimesters of pregnancy, particularly when compared to pharmacological treatments. Much of the medical literature is composed of case studies of single or twin pregnancies, and although some have reported serious complications, the majority have found ECT to be safe.
Mechanism of actionEdit
The aim of ECT is to induce a therapeutic clonic seizure (a seizure where the person loses consciousness and has convulsions) lasting for at least 15 seconds. Although a large amount of research has been carried out, the exact mechanism of action of ECT remains elusive. The main reasons for this are the difficulty of isolating the therapeutic effect from the plethora of effects that accompany the anesthetic, electric shock and seizure; the differences between the brains of humans and those of other animals; and the lack of satisfactory animal models of mental illness.
It is widely acknowledged internationally that written informed consent is as important in ECT as other medical treatments. The World Health Organization, in its 2005 publication "Human Rights and Legislation WHO Resource Book on Mental Health," specifically states, "ECT should be administered only after obtaining informed consent."
In the US, this doctrine places a legal obligation on a doctor to make a patient aware of: the reason for treatment, the risks and benefits of a proposed treatment, the risks and benefits of alternative treatment, and the risks and benefits of receiving no treatment. The patient is then given the opportunity to accept or reject the treatment. The form states how many treatments are recommended and also makes the patient aware that the treatment may be revoked at anytime during a course of ECT. The Surgeon General's report on mental health said that patients should be warned that the benefits of ECT are short-lived without active continuation treatment in the form of drugs or further ECT and that there may be some risk of permanent severe memory loss after ECT. The report advised psychiatrists to involve patients in discussion, possibly with the aid of leaflets or videos, both before and during a course of ECT.
To demonstrate what would be required to fully satisfy the legal obligation for 'informed consent', one psychiatrist, working for an antipsychiatry organisation, has formulated his own 'consent form' using the Texas Legislature as a model. It should be noted that printed or videotaped materials regarding ECT might be commissioned by the manufacturers of the equipment used, and so the possibility of this information leaning towards confirmation bias should be considered. Some question the effects of drugs on the ability to give informed consent.
In the UK in order for consent to be valid it requires an explanation in "broad terms" of the nature of the procedure and its likely effects. One review from 2005 found that only about half of patients felt they were given sufficient information about ECT and its adverse effects, and another survey found that about fifty percent of psychiatrists and nurses agreed with them.
Procedures for involuntary ECT vary from country to country depending on local mental health laws. Legal proceedings are required in some countries, while in others ECT is seen as another form of treatment that may be given involuntarily as long as legal conditions are observed.
In the USA, the Surgeon General's report on mental health requires a judicial proceeding, at which patients may be represented by legal counsel, prior to initiation of involuntary ECT, stating: "As a rule, the law requires that such petitions are granted only where the prompt institution of ECT is regarded as potentially lifesaving, as in the case of a person in grave danger because of lack of food or fluid intake caused by catatonia."
In England and Wales the Mental Health Act 1983 currently allows the use of ECT on detained patients (with and without capacity) if the treatment is likely to alleviate or prevent deterioration in a condition and is authorized by a psychiatrist from the Mental Health Act Commission's panel. However, proposed amendments to the Mental Health Act (clause 30) will introduce a capacity-threshold for the imposition of ECT. This in effect will mean that ECT may not be given to a patient who has capacity to refuse to consent to it, irrespective of his or her detention under the Act (the treatment may still be given in an emergency under s62). If the treating psychiatrist thinks the need for treatment is urgent they may start a course of ECT before authorization. About 2,000 people a year in England and Wales are treated without their consent under the Mental Health Act, with a small number of informal patients treated in this way under common law. In Scotland the Mental Health (Care and Treatment) (Scotland) Act 2003 gives patients with capacity the right to refuse ECT.
A study published in 2005 in the "British Journal of Psychiatry" described patients' perspectives of electroshock. The study stated, “About half (45-55%) of patients reported they were given an adequate explanation of ECT, implying a similar percentage felt they were not.” The study also said, “Approximately a third did not feel they had freely consented to ECT even when they had signed a consent form. [deletion] The proportion who feel they did not freely choose the treatment has actually increased over time. The same themes arise whether the patient had received treatment a year ago or 30 years ago. [deletion] Neither current nor proposed safeguards for patients are sufficient to ensure informed consent with respect to ECT, at least in England and Wales.”
Duress in involuntary ECT makes reports about its effects, by patients while under duress, uncertain in their validity. Megara Sanderson, Events & Culture Editor of newspaper "The Flying Horse" reports, "Some speculate that patients may pretend that they are cured of their mental illness so that they no longer have to endure the electro-convulsive treatment."
Involuntary electroshock contravenes the principle of autonomy in medical ethics. The maxim of autonomy is "Voluntas aegroti suprema lex." This rule states that the will of the patient is supreme. It implies that a patient has the right to refuse a medical treatment, such as ECT.
As early as the 16th century, agents to produce seizures were used to treat psychiatric conditions. In 1785 the therapeutic use of seizure induction was documented in the London Medical Journal. Convulsive therapy was introduced in 1934 by Hungarian neuropsychiatrist Ladislas J. Meduna who, believing mistakenly that schizophrenia and epilepsy were antagonistic disorders, induced seizures with first camphor and then metrazol (cardiazol). Within three years metrazol convulsive therapy was being used worldwide. In 1937, the first international meeting on convulsive therapy was held in Switzerland by the Swiss psychiatrist Muller. The proceedings were published in the American Journal of Psychiatry and, within three years, cardiazol convulsive therapy was being used worldwide. Italian Professor of neuropsychiatry Ugo Cerletti, who had been using electric shocks to produce seizures in animal experiments, and his colleague Lucio Bini developed the idea of using electricity as a substitute for metrazol in convulsive therapy and, in 1937, experimented for the first time on a person. ECT soon replaced metrazol therapy all over the world because it was cheaper, less frightening and more convenient. Cerletti and Bini were nominated for a Nobel Prize but did not receive one. By 1940, the procedure was introduced to both England and the US. Through the 40's and 50's the use of ECT became widespread. ECT is the only form of shock treatment still performed by modern medicine.
In the early 1940s, in an attempt to reduce the memory disturbance and confusion associated with treatment, two modifications were introduced: the use of unilateral electrode placement and the replacement of sinusoidal current with brief pulse. It took many years for brief-pulse equipment to be widely adopted Unilateral ECT has never been popular with psychiatrists and is still only given to a minority of ECT patients. In the 1940s and early 1950s ECT was usually given in "unmodified" form, without muscle relaxants, and the seizure resulted in a full-scale convulsion. A rare but serious complication of unmodified ECT was fracture or dislocation of the long bones. In the 1940s psychiatrists began to experiment with curare, the muscle-paralysing South American poison, in order to modify the convulsions. The introduction of suxamethonium (succinylcholine), a safer synthetic alternative to curare, in 1951 led to the more widespread use of "modified" ECT. A short-acting anesthetic was usually given in addition to the muscle relaxant in order to spare patients the terrifying feeling of suffocation that can be experienced with muscle relaxants.
The steady growth of antidepressant use along with negative depictions of ECT in the mass media led to a marked decline in the use of ECT during the 50's to the 70's. The Surgeon General stated there were problems with electroshock therapy in the initial years before anesthesia was routinely given and, these now antiquated practices contributed to the negative portrayal of ECT in the popular media. The New York Times described the public's negative perception of ECT as being caused mainly by one movie,"For Big Nurse in One Flew Over the Cuckoo's Nest, it was a tool of terror, and in the public mind shock therapy has retained the tarnished image given it by Ken Kesey's novel: dangerous, inhumane and overused".
In 1976 Dr. Blatchley demonstrated the effectiveness of his constant current, brief pulse device ECT. This device eventually largely replaced earlier devices because of the reduction in cognitive side effects, although some ECT clinics in the US still use sine-wave devices. The 1970s saw the publication of the first American Psychiatric Association task force report on electroconvulsive therapy (to be followed by further reports in 1990 and 2001). The report endorsed the use of ECT in the treatment of depression. The decade also saw criticism of ECT. Specifically critics pointed to shortcomings such as noted side effects, the procedure being used as a form of abuse, and uneven application of ECT. The use of ECT declined until the 1980s, "when use began to increase amid growing awareness of its benefits and cost-effectiveness for treating severe depression". In 1985 the National Institute of Mental Health and National Institutes of Health convened a consensus development conference on ECT and concluded that, whilst ECT was the most controversial treatment in psychiatry and had significant side-effects, it had been shown to be effective for a narrow range of severe psychiatric disorders.</blockquote>
Due to the backlash noted previously, national institutions reviewed past practices and set new standards. In 1978 The American Psychiatric Association released its first task force report in which new standards for consent were introduced and the use of unilateral electrode placement was recommended. The 1985 NIMH Consensus Conference confirmed the therapeutic role of ECT in certain circumstances. The American Psychiatric Association released its second task force report in 1990 where specific details on the delivery, education, and training of ECT were documented. Finally in 2001 the American Psychiatric Association released its latest task force report. This report emphasizes the importance of informed consent, and the expanded role that the procedure has in modern medicine.
The APA ECT taskforce guidelines report findings that most patients find ECT no worse than going to the dentist, and many found it less stressful than the dentist. They report that other research finds that most patients would voluntarily receive ECT again if needed.
NICE ECT guidelines report that some individuals consider ECT to have been a beneficial and lifesaving treatment, while others reported feelings of terror, shame and distress, and found it positively harmful and an abusive invasion of personal autonomy, especially when administered without their consent.
Individual positive depictionsEdit
Kitty Dukakis, wife of politician Michael Dukakis, reports in a Newsweek article mostly positive effects from electroconvulsive therapy, and regards memory loss as an acceptable price to pay for relief from depression.
[For me,] the memory issues are real but manageable. Things I lose generally come back. Other memories I prefer to lose, including those about the depression I was suffering. But there are some memories—of meetings I have attended, people's homes I have visited—that I don't want to lose but I can't help it. They generally involve things I did two weeks before and two weeks after ECT. Often they are just wiped out....I have learned ways to partly compensate for whatever loss I still experience. I call my sister Jinny, Michael and my kids, asking what my niece Betsy's phone number is, what we did yesterday and what we are planning to do tomorrow. I apologize prior to asking. I wonder when they are going to run out of patience with "Kitty being Kitty." I hate losing memories, which means losing control over my past and my mind, but the control ECT gives me over my disabling depression is worth this relatively minor cost. It just is.—
American psychotherapist Martha Manning's autobiographical Undercurrents acknowledges the downside of treatment: "I felt like I'd been hit by a truck for a while, but that was, comparatively speaking, not so bad," as well as the upside: "Afterwards, I thought, do regular people feel this way all the time? It's like you've not been in on a great joke for the whole of your life."
In his autobiographical book Electroboy, American writer Andy Behrman describes undergoing ECT as a treatment for bipolar disorder while under house-arrest: "I wake up thirty minutes later and think I am in a hotel in Acapulco. My head feels as if I have just downed a frozen margarita too quickly. My jaws and limbs ache. But I am elated."
Curtis Hartmann, a lawyer in western Massachusetts, stated: "ECT, a treatment of last resort for severe, debilitating depression, is all that has ever worked for me. I awaken about 20 minutes later, and although I am still groggy with anesthesia, much of the hellish depression is gone. It is a disease that for me, literally steals me from myself—a disease that executes me and then forces me to stand and look down at my corpse. Thankfully, ECT has kept my monster at bay, my hope intact".
Individual negative depictionsEdit
Negative effects of ECT have been reported by noteworthy individuals.
Ernest Hemingway, American author, committed suicide shortly after ECT treatment at the Menninger Clinic in 1961. He is reported to have said to his biographer, "Well, what is the sense of ruining my head and erasing my memory, which is my capital, and putting me out of business? It was a brilliant cure but we lost the patient...."
In 2005, "Peggy S. Salters, 60, sued Palmetto Baptist Medical Center in Columbia, as well as the three doctors responsible for her care. As the result of an intensive course of outpatient ECT in 2000, she lost all memories of the past 30 years of her life, including all memories of her husband of three decades, now deceased, and the births of her three children. Ms. Salters held a Masters of Science in nursing and had a long career as a psychiatric nurse, but lost her knowledge of nursing skills and was unable to return to work after ECT." The jury awarded Salters $635,177 in compensation for her inability to work.
Registered nurse Barbara C. Cody reports in a letter to the Washington Post that her life was forever changed by 13 outpatient ECTs she received in 1983. "Shock 'therapy' totally and permanently disabled me. EEGs [electroencephalograms] verify the extensive damage shock did to my brain. Fifteen to 20 years of my life were simply erased; only small bits and pieces have returned. I was also left with short-term memory impairment and serious cognitive deficits. [deletion] Shock "therapy" took my past, my college education, my musical abilities, even the knowledge that my children were, in fact, my children. I call ECT a rape of the soul."
In 2007, a judge canceled a two year old court order that allowed the involuntary electroshock of Simone D., a psychiatric patient at Creedmoor Psychiatric Center in the state of New York. Although Simone spoke only Spanish, she rarely received access to staff fluent in her language. Simone previously had 200 electroshocks. However, she communicated that she did not want more electroshock. Simone stated, "Electroshock causes more pain. I suffer more from shock treatment!"
In 2008, David Tarloff, a psychiatric patient who had received electroshock, assaulted two therapists in the city of New York. Tarloff injured one therapist and murdered the other. One of the therapists was Kent Shinbach, a psychiatrist who had an interest in electroconvulsive therapy. "It is not clear whether Dr. Shinbach played any role in Mr. Tarloff's shock therapy". However, Tarloff told investigators that Shinbach had given Tarloff psychiatric treatment at a psychiatric facility initially in 1991.
In an interview with "Houston Chronicle"in 1996, Melissa Holliday, a former extra on "Baywatch" and model for "Playboy" stated the ECT she received in 1995, "ruined her life". She went on to state, "I've been through a rape, and electroshock therapy is worse. If you haven't gone through it, I can't explain it"
Liz Spikol the senior contributing editor of Philadelphia Weekly, wrote of her ECT in 1996, "Not only was the ECT ineffective, it was incredibly damaging to my cognitive functioning and memory. But sometimes it's hard to be sure of yourself when everyone "credible"—scientists, ECT docs, researchers—are telling you that your reality isn't real. How many times have I been told my memory loss wasn't due to ECT but to depression? How many times have I been told that, like a lot of other consumers, I must be perceiving this incorrectly? How many times have people told me that my feelings of trauma related to the ECT are misplaced and unusual? It's as if I was raped and people kept telling me not to be upset—that it wasn't that bad."
Public perception and mass mediaEdit
A questionnaire survey of 379 members of the general public in Australia indicated that more than 60% of respondents had some knowledge about the main aspects of ECT. Participants were generally opposed to the use of ECT on depressed individuals with psychosocial issues, on children, and on involuntary patients. Public perceptions of ECT were found to be mainly negative.
Fictional and semi-fictional depictionsEdit
Electroconvulsive therapy has been depicted in several fictional and semi-fictional films, books, television shows and songs, such as in Requiem for a Dream, One Flew Over the Cuckoo's Nest, House (TV series) and A Beautiful Mind' (The actual ECT procedure was not demonstrated, but rather an older and effectively similar procedure known as Insulin Shock Therapy. This procedure is rarely used today.)
Famous people who have undergone ECT Edit
|The lists in this article may contain items which are not notable, encyclopedic, or helpful. Please help out by removing such elements and incorporating appropriate items into the main body of the article. (June 2008)|
- Antonin Artaud, French playwright
- Miles Buchanan, brother of Australian actress Simone Buchanan
- Paulo Coelho, author of The Alchemist 
- Kitty Dukakis, wife of former Massachusetts governor and 1988 Democratic presidential nominee Michael Dukakis and author of Shock, a book chronicling her experiences with ECT.
- Thomas Eagleton, US senator and vice presidential candidate
- Roky Erickson, American singer, songwriter, harmonica player and guitarist.
- Janet Frame, New Zealand writer and poet.
- Romulus Gaita, father of Australian philosopher Raimond Gaita
- Judy Garland, actress
- Harold Gimblett, British cricketer. "Rita [his wife] came to see me and couldn't believe the difference. I had some colour back in my cheeks..."
- Peter Green, English blues guitarist, founding member of Fleetwood Mac
- David Helfgott, Australian pianist.
- Ernest Hemingway, American Pulitzer Prize winning novelist, short-story writer, and journalist. 
- Marya Hornbacher, American writer. 
- Michael Moriarty, American actor.
- Sherwin B. Nuland, American surgeon and writer
- Sylvia Plath, American writer and poet.
- Lou Reed, The Velvet Underground
- Yves Saint-Laurent, French fashion designer.
- Townes van Zandt, American country singer-songwriter.
- Vivien Leigh, English Actress and second wife of Laurence Olivier
- Robert M. Pirsig, American author of Zen and the Art of Motorcycle Maintenance 
- David Foster Wallace, American writer
- Gene Tierney, American Actress
- ↑ Scott AIF (ed) et al. (2005). "The ECT Handbook Second Edition: The Third Report of the Royal College of Psychiatrists' Special Committee on ECT" (pdf). Royal College of Psychiatrists. Retrieved on 2008-07-26.
- ↑ Psychology Frontiers and Applications - Second Canadian Edition (Passer, Smith, Atkinson, Mitchell, Muir)
- ↑ "Electroconvulsive therapy discussion hosted at the MGH". Retrieved on 2007-06-05.
- ↑ McCall WV, Prudic J, Olfson M, Sackeim H (February 2006). "Health-related quality of life following ECT in a large community sample". J Affect Disord 90 (2-3): 269–74. doi:10.1016/j.jad.2005.12.002. PMID 16412519.
- ↑ 5.0 5.1 American Psychiatric Association. "Electroconvulsive Therapy (ECT)". Retrieved on 2007-12-29.
- ↑ 6.0 6.1 6.2 6.3 "Guidance on the use of electroconvulsive therapy" (pdf). National Institute for Clinical Excellence (2005-11-01). Retrieved on 2008-07-26.
- ↑ 7.0 7.1 Sackeim HA, Prudic J, Fuller R, Keilp J, Lavori PW, Olfson M (January 2007). "The cognitive effects of electroconvulsive therapy in community settings". Neuropsychopharmacology 32 (1): 244–54. doi:10.1038/sj.npp.1301180. PMID 16936712.
- ↑ Shock Therapy Makes a Comeback: States Respond
- ↑ 9.0 9.1 Mental Health: A Report of the Surgeon General - Chapter 4. Retrieved 2007-12-29.
- ↑ Task Force on Electroconvulsive Therapy. The practice of electroconvulsive therapy: recommendations for treatment, training, and privileging. 2nd ed. Washington, DC: American Psychiatric Publishing, 2001.
- ↑ Lisanby, S.H. (2007) Electroconvulsive Therapy for Depression Volume 357, No. 19, p1939-1945
- ↑ 12.00 12.01 12.02 12.03 12.04 12.05 12.06 12.07 12.08 12.09 12.10 12.11 12.12 12.13 12.14 12.15 12.16 Rudorfer, MV, Henry, ME, Sackeim, HA (2003). "Electroconvulsive therapy". In A Tasman, J Kay, JA Lieberman (eds) Psychiatry, Second Edition. Chichester: John Wiley & Sons Ltd, 1865-1901.
- ↑ 13.0 13.1 13.2 Reid WH, Keller S, Leatherman M, Mason M (January 1998). "ECT in Texas: 19 months of mandatory reporting". J Clin Psychiatry 59 (1): 8–13. PMID 9491059.
- ↑ Euba R, Saiz A (2006). "A comparison of the ethnic distribution in the depressed inpatient population and in the electroconvulsive therapy clinic". J ECT 22 (4): 235–6. doi:10.1097/01.yct.0000235928.39279.52. PMID 17143151.
- ↑ 15.0 15.1 15.2 15.3 15.4 Surgeon General (1999). Mental Health: A Report of the Surgeon General, chapter 4.
- ↑ Prudic J, Olfson M, Marcus SC, Fuller RB, Sackeim HA (2004). "Effectiveness of electroconvulsive therapy in community settings". Biol. Psychiatry 55 (3): 301–12. doi:10.1016/j.biopsych.2003.09.015. PMID 14744473.
- ↑ 17.0 17.1 17.2 17.3 17.4 Prudic J, Olfson M, Sackeim HA (July 2001). "Electro-convulsive therapy practices in the community". Psychol Med 31 (5): 929–34. PMID 11459391.
- ↑ The UK ECT Review Group (2003). "Efficacy and safety of electroconvulsive therapy in depressive disorders: a systemic review and meta-analysis". Lancet 361:799-808.
- ↑ Sackeim HA, Haskett RF, Mulsant BH, Thase ME, Mann JJ, Pettinati HM, Greenberg RM, Crowe RR, Cooper TB, Prudic J.(2001) Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA. 2001 Mar 14;285(10):1299-307.
- ↑ Tew JD Jr, Mulsant BH, Haskett RF, Joan P, Begley AE, Sackeim HA. (2007) Relapse during continuation pharmacotherapy after acute response to ECT: a comparison of usual care versus protocolized treatment] Ann Clin Psychiatry. 2007 Jan-Mar;19(1):1-4 PMID 17453654
- ↑ Kellner CH, Knapp RG, Petrides G, Rummans TA, Husain MM, Rasmussen K, Mueller M, Bernstein HJ, O'Connor K, Smith G, Biggs M, Bailine SH, Malur C, Yim E, McClintock S, Sampson S, Fink M. (2006) Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Arch Gen Psychiatry. 2006 Dec;63(12):1337-44. PMID 17146008
- ↑ 22.0 22.1 Duffett R, Lelliott P (1998). "Auditing electroconvulsive therapy. The third cycle". Br J Psychiatry 172: 401–5. PMID 9747401.
- ↑ 23.0 23.1 Lock, T (1995). "Stimulus dosing". In C Freeman (ed.) The ECT Handbook. London: Royal College of Psychiatrists, 72-87.
- ↑ Federal Register (1979), p. 51776
- ↑ See the Slovenian government website for information about ECT in Slovenia.
- ↑ Motohashi N, Awata S, Higuchi T (2004). "A questionnaire survey of ECT practice in university hospitals and national hospitals in Japan". J ECT 20 (1): 21–3. PMID 15087992.
- ↑ Chanpattana W, Kunigiri G, Kramer BA, Gangadhar BN (2005). "Survey of the practice of electroconvulsive therapy in teaching hospitals in India". J ECT 21 (2): 100–4. PMID 15905751.
- ↑ Ikeji OC, Ohaeri JU, Osahon RO, Agidee RO (1999). "Naturalistic comparative study of outcome and cognitive effects of unmodified electro-convulsive therapy in schizophrenia, mania and severe depression in Nigeria". East Afr Med J 76 (11): 644–50. PMID 10734527.
- ↑ "Abusive practice of "unmodified" electroshock treatment abolished at main psychiatric facility of Turkey". Disabled Peoples' International. Retrieved on 2008-03-25.
- ↑ Dutta, Rita (2003). "Psychiatrists plead against ban of direct electro convulsive therapy". Indian Express Group of Newspapers. Retrieved on 2007-12-31.
- ↑ Hermann R, Dorwart R, Hoover C, Brody J (1995). "Variation in ECT use in the United States". Am J Psychiatry 152 (6): 869–75. PMID 7755116.
- ↑ Cauchon, Dennis (1995-12-06). "Patients often aren't informed of full danger", USA Today.
- ↑ Texas Department of State (2002) Electroconvulsive therapy reports.
- ↑ Fink, M. & Taylor, A.M. (2007) Electroconvulsive therapy: Evidence and Challenges JAMA Vol. 298 No. 3, p330-332.
- ↑ Pippard, J and Ellam, L (1981). Electroconvulsive treatment in Great Britain, 1980. London: Gaskell.
- ↑ Pippard J, Ellam L (1981). "Electroconvulsion treatment in Great Britain 1980". Lancet 2 (8256): 1160–1. PMID 6118592.
- ↑ Electro convulsive therapy: survey covering the period from January 2002 to March 2002, Statistical Bulletin 2003/08. Department of Health.
- ↑ NICE 2003. Electroconvulsive therapy (ECT). Retrieved on 2007-12-29.
- ↑ Carney, S & Geddes, J (2003). "Electroconvulsive therapy: recent recommendations are likely to improve standards and uniformity of use". British Medical Journal 326: 1343-4.
- ↑ NICE (2003). Appraisal of electroconvulsive therapy: decision of the appeal panel. London: NICE.
- ↑ Duffett, R and Lelliot, P (1998). "Auditing electroconvulsive therapy: the third cycle". British Journal of Psychiatry 172:401-405.
- ↑ Royal College of Psychiatrists (2006). ECTAS newsletter issue 5.
- ↑ Author: Sarah Hall. Web page: “Rise in electric shock therapy in county.” Web site: "Norwich Evening News 24.” Date: June 4, 2008. Institution: Archant Regional. Date of access: June 4, 2008. Web address: http://www.eveningnews24.co.uk/search/story.aspx?brand=ENOnline&category=News&itemid=NOED03%20Jun%202008%2012:55:17:717&tBrand=ENOnline&tCategory=search.
- ↑ 44.0 44.1 Lisanby SH, Maddox JH, Prudic J, Devanand DP, Sackeim HA (June 2000). "The effects of electroconvulsive therapy on memory of autobiographical and public events". Arch. Gen. Psychiatry 57 (6): 581–90. PMID 10839336, http://archpsyc.ama-assn.org/cgi/pmidlookup?view=long&pmid=10839336.
- ↑ 45.0 45.1 45.2 Benbow, SM (2004) "Adverse effects of ECT". In AIF Scott (ed.) The ECT Handbook, second edition. London: The Royal College of Psychiatrists, pp.170-174.
- ↑ Squire LR, Slater PC, Miller PL (January 1981). "Retrograde amnesia and bilateral electroconvulsive therapy. Long-term follow-up". Arch. Gen. Psychiatry 38 (1): 89–95. PMID 7458573.
- ↑ Squire LR, Slater PC (January 1983). "Electroconvulsive therapy and complaints of memory dysfunction: a prospective three-year follow-up study". Br J Psychiatry 142: 1–8. PMID 6831121.
- ↑ Fink M (2007). "Complaints of loss of personal memories after electroconvulsive therapy: evidence of a somatoform disorder?". Psychosomatics 48 (4): 290–3. doi:10.1176/appi.psy.48.4.290. PMID 17600164.
- ↑ Rose, D et al. (2003). "Patients' perspectives on electroconvulsive therapy: systematic review". "British Medical Journal 326:1363-1365.
- ↑ FDA, Docket #82P-0316
- ↑ See for example, Andre, L (2001). Testimony at the public hearing of the NY State (US) Assembly Standing Committee on Mental Health on electroconvulsive therapy; Donahue, A (12 March 1999). Testimony at the public hearing of the Vermont (US) Health and Welfare Committee on electroconvulsive therapy.
- ↑ Mangaoang, MA and Lacey, JV (2007). "Cognitive rehabilitation: assessment and treatment of persistent memory impairments following ECT". Advances in Psychiatry 13: 90-100.
- ↑ Philpot M, Collins C, Trivedi P, Treloar A, Gallacher S, Rose D: Eliciting users’ views of ECT in two mental health trusts with a user-designed questionnaire. Journal of Mental Health 13(4): 403-413, 2004
- ↑ Devanand DP, Dwork AJ, Hutchinson ER, Bolwig TG, Sackeim HA (1994). "Does ECT alter brain structure?". Am J Psychiatry 151 (7): 957–70. PMID 8010381.
- ↑ Primary Psychiatry: In Session with Charles H. Kellner, MD: Current Developments in Electroconvulsive Therapy
- ↑ Miller LJ (May 1994). "Use of electroconvulsive therapy during pregnancy". Hosp Community Psychiatry 45 (5): 444–50. PMID 8045538, http://ps.psychiatryonline.org/cgi/pmidlookup?view=long&pmid=8045538.
- ↑ Walker R, Swartz CM (September 1994). "Electroconvulsive therapy during high-risk pregnancy". Gen Hosp Psychiatry 16 (5): 348–53. PMID 7995506.
- ↑ Ferrill MJ, Kehoe WA, Jacisin JJ (1992). "ECT During Pregnancy: Physiologic and Pharmacologic Considerations". Convuls Ther 8 (3): 186–200. PMID 11941169.
- ↑ e.g. PMID 10668602 (death) (French), PMID 10074880 (premature labour), PMID 9871846 (spontaneous abortion)
- ↑ Pinette MG, Santarpio C, Wax JR, Blackstone J (August 2007). "Electroconvulsive therapy in pregnancy". Obstet Gynecol 110 (2 Pt 2): 465–6. doi:10.1097/01.AOG.0000265588.79929.98 (inactive 8 September 2008). PMID 17666629.
- ↑ e.g. PMID 14560648, PMID 17804997, PMID 11593722, PMID 10614034 (two patients), PMID 8198651 (twins), PMID 11941159 (twins), PMID 2246991
- ↑ Bocchio-Chiavetto L, Zanardini R, Bortolomasi M, et al (2006). "Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients". Eur Neuropsychopharmacol 16 (8): 620–4. doi:10.1016/j.euroneuro.2006.04.010. PMID 16757154.
- ↑ World Health Organisation (2005). WHO Resource Book on Mental Health, Human Rights and Legislation. Geneva, 64.
- ↑ Johnson, R. "An informed consent form for electroconvulsive therapy, draft 1." (PDF). PsychRights.
- ↑ Texas Legislature (2004). Health & safety code Chapter 578. Electroconvulsive and other therapies Sec.578.001.
- ↑ Jones, R (1996) Mental Health Act Manual, 5th edition. London: Sweet and Maxwell, page 225.
- ↑ Rose, DS et al. (2005)"Information, consent and perceived co-ercion: patients' perspectives on electroconvulsive therapy". British Journal of Psychiatry 186:54-59.
- ↑ Lutchman, RD et al. (2001). "Mental health professionals' attitudes towards and knowledge of electroconvulsive therapy." Journal of Mental Health 10(20):141-150.
- ↑ The Mental Health Act 1983, Part 4, section 58.
- ↑ The Mental Health Act 1983, Part 4, section 62.
- ↑ The Mental Health Act Commission (2005) In Place of Fear? eleventh biennial report, 2003-2005, 236. The Stationery Office.
- ↑ The Mental Health (Care and Treatment) (Scotland) Act 2003, Part 16, sections 237-239.
- ↑ Rose D, Wykes T, Bindman J, Fleischmann P: Information, consent and perceived coercion: patients’ perspectives on electroconvulsive therapy. British Journal of Psychiatry 186: 54-59, 2005.
- ↑ Author: Megara Sanderson. Web page: “A Shocking Experience.” Web site: “The Flying Horse.” Date: April 14, 2008. Institution: Middlesex Community College. Date of access: May 2, 2008. Web address: http://theflyinghorse.net/wp/?p=101.
- ↑ Author: Megara Sanderson. Article: “A Shocking Experience.” Periodical: “The Flying Horse.” Volume: 2. Issue: 4. Date: May 2008. Institution: Middlesex Community College.
- ↑ 76.0 76.1 Fink, M (1984). "The origins of convulsive therapy". American Journal of Psychiatry 141:1034-41.
- ↑ Cerletti, U (1956). "Electroshock therapy". In AM Sackler et al. (eds) The Great Physiodynamic Therapies in Psychiatry: an historical appraisal. New York: Hoeber-Harper, 91-120.
- ↑ 78.0 78.1 Kiloh, LG, Smith, JS, Johnson, GF (1988). Physical Treatments in Psychiatry. Melbourne: Blackwell Scientific Publications, 190-208. ISBN 0-86793-112-4
- ↑ 79.0 79.1 Goode, Erica (1999-10-06). "Federal Report Praising Electroshock Stirs Uproar". New York Times. Retrieved on 2008-01-01.
- ↑ Goleman, Daniel (1990-08-02). "The Quiet Comeback of Electroshock Therapy". New York Times. Retrieved on 2008-01-01.
- ↑ See Friedberg, J (1977). "Shock treatment, brain damage, and memory loss: a neurological perspective". American Journal of Psychiatry 134:1010-1014; and Breggin, PR (1979) Electroshock: its brain-disabling effects. New York: Springer
- ↑ Blaine, JD and Clark, SM (1986). "Report of the NIMH-NIH consensus development conference on Electroconvulsive therapy". Psychopharmacology Bulletin 22(2): 445-452.
- ↑ 83.0 83.1 Dukakis, K and Tye, L (2006), excerpt from 'I Feel Good, I Feel Alive'. Newsweek September 18:62-63.
- ↑ Manning, Martha (March 1996). Undercurrents: A Therapist's Reckoning with Her Own Depression, Harper San Francisco. ISBN 978-0062511843.
- ↑ Behrman, Andy (February 2003). Electroboy: A Memoir of Mania, Random House. ISBN 978-0812967081.
- ↑ Personal Accounts: Life as Death: Hope Regained With ECT - Hartmann 53 (4): 413 - Psychiatr Serv
- ↑ A. E. Hotchner, Papa Hemingway: A Personal Memoir, ISBN 0786705922; pg 280
- ↑ ECT verdict awards dollar judgment
- ↑ Cody, Barbara (Approximately between 1995-2006). "Letter". HealthyPlace.com. Retrieved on 2006-09-23.
- ↑ 90.0 90.1 90.2 90.3 90.4 Author: MindFreedom International. Web page: “Another victory against forced electroshock. Simone D. wins!” Web site: “MindFreedom International.” Date: August 28, 2007. Institution: MindFreedom International. Date of access: April 18, 2008. Web address: http://www.mindfreedom.org/campaign/kb/mental-health-abuse/electroshock/simone-d.
- ↑ 91.0 91.1 91.2 Author: Lauren Tenney. Web page: “Testimony from Lauren Tenney, Member of FUTURE Views and the Mental Patients Liberation Alliance.” Web site: “New York State Office of Mental Health.” Date: October 5, 2007. Institution: New York State Office of Mental Health. Date of access: April 18, 2008. Web address: http://www.omh.state.ny.us/omhweb/statewideplan/2006/testimony/507/nyc/tenney.html.
- ↑ Shock Therapy Emerges As Detail in Therapist's Killing - February 21, 2008 - The New York Sun
- ↑ Christopher Faherty (2008-04-02). "Suspected Killer 'Didn't Mean To Hurt Anyone'". Retrieved on 2008-04-13.
- ↑ Woman Says Electric Shock Treatment Destroyed Her Life
- ↑ http://trouble.philadelphiaweekly.com/archives/2006/12/funday_ect_stud.html.
- ↑ Teh, S.P.C., Helmes, E. & Drake, D. (2007) A Western Australian Survey On Public Attitudes Toward and Knowledge of Electroconvulsive Therapy International Journal of Social Psychiatry, Vol. 53, No. 3, 247-271 (2007) DOI: 10.1177/0020764006074522
- ↑ Barber, Stephen (February 2005). The Screaming Body: Antonin Artaud - Film Projects, Drawings and Sound Recordings, Creation Books. ISBN 978-1840680911.
- ↑ Coelho, Paulo (2006). The Zahir, HarperCollinsPublishers. ISBN 978-0-0-721362-7.
- ↑ Dukakis, Kitty; Tye, Larry (September 2006). Shock: The Healing Power of Electroconvulsive Therapy, Avery. ISBN 978-1583332658.
- ↑ "The White House losers". The Guardian (2008-03-29). Retrieved on 2008-03-29.
- ↑ Dallas - Music - Roky Erickson
- ↑ Frame, J. An Angel at My Table, London, Virago, 2008 (autobiography)
- ↑ Author: Citizens Commission on Human Rights. Web page: “Harming Artists: Psychiatry Ruins Creativity.” Web site: “Psychiatric Abuse.” Date: 2004. Institution: Citizens Commission on Human Rights. Date of access: May 28, 2008. Web address: http://www.psychiatric-abuse.org.uk/Harming%20Artists.pdf.
- ↑ "Tale of a tormented genius". Retrieved on 2007-06-12.
- ↑ Peter Green Biography
- ↑ Denis Dutton on David Helfgott
- ↑ 
- ↑ Hornbacher, Marya. Madness: A Bipolar Life, New York, 2008 (autobiography)
- ↑ Moriarty tames his demons
- ↑ Sherwin Nuland (2001) My history of electroshock therapy, TED lecture
- ↑ Sylvia Plath Homepage
- ↑ Electroshock Therapy Treatment - ECT and how it works
- ↑ The Biography Channel - Yves Saint Laurent Biography
- ↑ See the biographical film, Be Here to Love Me.
- ↑ Famous Shock Patients
- ↑ David Foster Wallace, Influential Writer, Dies at 46
- American Psychiatric Association on ECT - brief article from the American Psychiatric Association.
- MIND on ECT - information on ECT from MIND (leading mental health charity in England and Wales).
- About to have ECT? ... - Psychiatric Times article on the portrayal of ECT by Hollywood
- TED talk on ECT - 30-year-practicing surgeon and successful writer Sherwin B. Nuland on the history of ECT and his personal experience with it.
da:ECT de:Elektrokrampftherapie et:Elekterkrampravi es:Terapia electroconvulsiva fr:Sismothérapie it:Terapia elettroconvulsivante he:נזעי חשמל ku:Elektrokompûlsîv terapî lt:Elektrokonvulsinė terapija hu:Elektrosokk-terápia nl:Elektroconvulsietherapie ja:電気けいれん療法 no:Elektrokonvulsiv terapi pl:Terapia elektrowstrząsowa pt:Eletroconvulsoterapia sr:Електрошок терапија fi:Sähköhoito sv:ECT zh:電痙攣療法